SKI Market

Indian Indices

Sensex

84,695.54 -345.91
( -0.41%)

Global Indices

Nasdaq

48,728.27 -23.90
(-0.05%)

Dow Jones

6,949.98 -3.07
(-0.04%)

Hang Seng

50,388.37 -362.02
(-0.71%)

Nikkei 225

9,870.68 -18.54
(-0.19%)

Forex

USD-INR

89.83 0.26
(0.29%)

EUR-INR

105.77 0.25
(0.24%)

GBP-INR

121.29 0.43
(0.36%)

JPY-INR

0.58 0.00
(0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cholamandalam Investment & Finance Company Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

511243

INE121A01024

310.4995502

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CHOLAFIN

30.83

143189.28

EPS(TTM)

Face Value()

Div & Yield %

55.04

0.12

Back

Ajanta Pharma consolidated net profit rises 20.19% in the September 2025 quarter

Nov 03,2025

Net profit of Ajanta Pharma rose 20.19% to Rs 260.19 crore in the quarter ended September 2025 as against Rs 216.48 crore during the previous quarter ended September 2024. Sales rose 14.08% to Rs 1353.73 crore in the quarter ended September 2025 as against Rs 1186.64 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1353.73	1186.64	14
OPM %	24.22	26.22	-
PBDT	383.78	324.63	18
PBT	340.81	290.24	17
NP	260.19	216.48	20

84,695.54 -345.91 ( -0.41%)

48,728.27 -23.90 (-0.05%)

6,949.98 -3.07 (-0.04%)

50,388.37 -362.02 (-0.71%)

9,870.68 -18.54 (-0.19%)

89.83 0.26 (0.29%)

105.77 0.25 (0.24%)

121.29 0.43 (0.36%)

0.58 0.00 (0.43%)